BioMarin submits EU marketing application for vosoritide

24th July 2020 Uncategorised 0

If approved, vosoritide would be the first medicine for the treatment of achondroplasia – the most common form of short stature – in Europe

More: BioMarin submits EU marketing application for vosoritide
Source: News